Pluristem Therapeutics To Participate In Upcoming Financial Conferences

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HAIFA, Israel, May 27, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that the Company’s COO, Yaky Yanay, and the Divisional VP for North America, Dr. Karine Kleinhaus, will participate in three upcoming financial conferences.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC